Indus corp:1108890 [19-007541]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95019P00669
- Awardee
-
Integrated Nonclinical Development Solutions Inc. UEI HBQ9UBHJJEN6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $160,441
Award facts
- Opportunity
-
- Toxicology Consultant Support Services Solicitation · NIHNINDSCSS19007546 · Posted Jul 1, 2019
- Contract value 36% obligated
-
- $160,440.75 Current, with exercised options
- $443,240.75 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Labor Hours
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $18,500 | |
| Other Administrative Action | -$46,759 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $46,250 | |
| Exercise an Option | $55,500 | |
| Exercise an Option | $18,500 | |
| Exercise an Option | $22,200 | |
| Exercise an Option | $18,500 | |
| Original award | $27,750 |
About this award
This is a $443,240.75 labor-hour purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a small business subchapter S corporation, to provide toxicology consultant support services for the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. The contract is a 100% small business set-aside and has a one-year base period with two one-year option periods. IND Solutions, a technology-enabled drug development and drug safety consultancy, will provide senior-level toxicology expertise and contribute feedback and guidance to BPN lead development teams working on nervous system drug candidates in the exploratory through preclinical safety stages, and potentially through investigational new drug (IND) and clinical trial stages.
Quick answers
Who was awarded contract 75N95019P00669?
75N95019P00669 was awarded to Integrated Nonclinical Development Solutions Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2019.
How much is contract 75N95019P00669 worth?
The government has obligated $160,441 on 75N95019P00669. Its potential value, with all options, is $443,241.
Was contract 75N95019P00669 competed?
The extent of competition for 75N95019P00669 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award